Mammary Neoplasms, Experimental
"Mammary Neoplasms, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
Descriptor ID |
D008325
|
MeSH Number(s) |
C04.588.531.500 C04.619.590 E05.598.500.496.843
|
Concept/Terms |
Mammary Neoplasms, Experimental- Mammary Neoplasms, Experimental
- Experimental Mammary Neoplasm
- Mammary Neoplasm, Experimental
- Neoplasm, Experimental Mammary
- Neoplasms, Experimental Mammary
- Experimental Mammary Neoplasms
|
Below are MeSH descriptors whose meaning is more general than "Mammary Neoplasms, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Mammary Neoplasms, Experimental".
This graph shows the total number of publications written about "Mammary Neoplasms, Experimental" by people in this website by year, and whether "Mammary Neoplasms, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 7 | 2 | 9 |
1995 | 7 | 2 | 9 |
1996 | 9 | 1 | 10 |
1997 | 8 | 1 | 9 |
1998 | 5 | 6 | 11 |
1999 | 8 | 3 | 11 |
2000 | 5 | 6 | 11 |
2001 | 10 | 1 | 11 |
2002 | 20 | 2 | 22 |
2003 | 9 | 0 | 9 |
2004 | 10 | 1 | 11 |
2005 | 12 | 2 | 14 |
2006 | 7 | 3 | 10 |
2007 | 14 | 2 | 16 |
2008 | 10 | 0 | 10 |
2009 | 17 | 2 | 19 |
2010 | 18 | 5 | 23 |
2011 | 10 | 7 | 17 |
2012 | 9 | 3 | 12 |
2013 | 7 | 1 | 8 |
2014 | 7 | 3 | 10 |
2015 | 4 | 3 | 7 |
2016 | 5 | 4 | 9 |
2017 | 4 | 3 | 7 |
2018 | 4 | 1 | 5 |
2019 | 3 | 4 | 7 |
2020 | 1 | 2 | 3 |
2021 | 2 | 2 | 4 |
2022 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mammary Neoplasms, Experimental" by people in Profiles.
-
p53R172H and p53R245W Hotspot Mutations Drive Distinct Transcriptomes in Mouse Mammary Tumors Through a Convergent Transcriptional Mediator. Cancer Res Commun. 2024 Aug 01; 4(8):1991-2007.
-
USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of function impacts MMTV promoter activity. PLoS One. 2024; 19(1):e0290837.
-
In Vivo Gene Delivery into Mouse Mammary Epithelial Cells Through Mammary Intraductal Injection. J Vis Exp. 2023 02 10; (192).
-
Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers. Proc Natl Acad Sci U S A. 2022 07 19; 119(29):e2123134119.
-
Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in?vitro and in?vivo studies. J Enzyme Inhib Med Chem. 2021 Dec; 36(1):954-963.
-
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer. Nat Commun. 2021 09 10; 12(1):5389.
-
Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer. Breast Cancer Res. 2021 08 05; 23(1):83.
-
ATF3-Induced Mammary Tumors Exhibit Molecular Features of Human Basal-Like Breast Cancer. Int J Mol Sci. 2021 Feb 26; 22(5).
-
Pan-cancer analysis reveals TAp63-regulated oncogenic lncRNAs that promote cancer progression through AKT activation. Nat Commun. 2020 10 14; 11(1):5156.
-
Using Computer-based Image Analysis to Improve Quantification of Lung Metastasis in the 4T1 Breast Cancer Model. J Vis Exp. 2020 10 02; (164).